`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner,
`
`v.
`
`COSMO TECHNOLOGIES LIMITED
`Patent Owner.
`
`___________________
`
`Case IPR2017-01035
`U.S. Patent No. 9,320,716
`___________________
`
`
`
`PATENT OWNER’S MANDATORY NOTICE
`PURSUANT TO 37 C.F.R. 42.8
`
`
`
`
`
`Mail Stop: PATENT BOARD
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`10028290
`
`
`- 1 -
`
`
`
`
`
`IPR2017-01035
`Patent No. 9,320,716
`
`
`
`Pursuant to 37 C.F.R. 42.8, Patent Owner Cosmo Technologies Limited
`
`hereby submits the following Notice.
`
`I.
`
`Real Party-In-Interest
`
`The real party-in-interest are Cosmo Technologies Limited, Cosmo
`
`Pharmaceuticals NV, Valeant Pharmaceuticals International, and Valeant
`
`Pharmaceuticals Luxembourg S.A R.L.
`
`II. Related Matters
`
`The following related ’716 patent family members exist: U.S. Patent No.
`
`7,410,651; U.S. Patent No. 8,784,888; U.S. Patent No. RE 43,799, formerly U.S.
`
`Patent No. 8,029,823; U.S. Patent No. 8,293,273; U.S. Patent No. 7,431,943; U.S.
`
`Patent No. 9,532,954; U.S. Patent No. 7,410,652; and U.S. App. No. 15/369,296.
`
`The ’716 patent is currently or has been the subject of the following
`
`litigations: Cosmo Technologies Limited et al. v. Mylan Pharmaceuticals Inc., 16-
`
`cv-00152 (D. Del.); Cosmo Technologies Ltd. et al. v. Lupin Ltd. et al, 15-cv-00669
`
`(D. Del.); Cosmo Technologies Limited et al. v. Alvogen Pine Brook, Inc., 15-cv-
`
`00193 (D. Del.); Cosmo Technologies Ltd et al. v Actavis Laboratories FL, Inc., 15-
`
`cv-00164 (D. Del.); Cosmo Technologies Limited et al. v. Par Pharmaceutical, Inc.,
`
`15-cv-00116 (D. Del.).
`
`10028290
`
`
`- 2 -
`
`
`
`
`
`IPR2017-01035
`Patent No. 9,320,716
`
`This Inter Partes Review is related to issued U.S. Patent No. 8,784,888 and
`
`the Inter Partes Review for that patent, IPR2017-01034.
`
`III. Lead And Back-Up Counsel
`
`LEAD COUNSEL
`Gary N. Frischling (Reg. No. 35,515)
`IRELL & MANELLA LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, California 90067
`Telephone: (310) 277-7597
`Facsimile: (310) 203-7199
`gfrischling@irell.com
`
`
`BACK-UP COUNSEL
`Yite John Lu (Reg. No. 63,158)
`IRELL & MANELLA LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, California 90067
`Telephone: (310) 277-7556
`Facsimile: (310) 556-5240
`yjlu@irell.com
`
`
`IV. Service Information
`
`Please address all correspondence to the lead and back-up counsel as shown
`
`above. The Patent Owner consent to electronic service to lead and back up counsel and
`
`to CosmoIPR@irell.com.
`
`Dated: March 30, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`/s/ Gary N. Frischling
`Gary N. Frischling
`Reg. No. 35,515
`
`Irell & Manella LLP
`1800 Avenue of the Stars, Suite 900
`Los Angeles, CA 90067-4276
`Telephone: (310) 277-1010
`Fax: (310) 203-7199
`
`Attorneys for Patent Owner
`
`10028290
`
`
`- 3 -
`
`
`
`
`
`IPR2017-01035
`Patent No. 9,320,716
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`Pursuant to 37 C.F.R. 42.6, the undersigned certifies that on March 30, 2017,
`
`a copy of the foregoing document and Patent Owner’s Power of Attorney were
`
`served by electronic mail upon the following:
`
`Jitendra Malik, Ph.D.
`Reg. No. 55,823
`ALSTON & BIRD LLP
`4721 Emperor Boulevard, Suite 400
`Durham, North Carolina 27703-8580
`919.862.2200
`jitty.malik@alston.com
`
`H. James Abe
`ALSTON & BIRD LLP
`333 South Hope Street, 16th Floor
`Los Angeles, CA 90071
`213.576.1000
`james.abe@alston.com
`
`Lance Soderstrom
`ALSTON & BIRD LLP
`90 Park Avenue, 15th Floor
`New York, New York 10016-1387
`212.210.9400
`lance.soderstrom@alston.com
`
`Joseph M. Janusz
`ALSTON & BIRD LLP
`101 S. Tryon Street, Suite 4000
`Charlotte, NC 28280
`704-444-1000
`joe.janusz@alston.com
`
`
`
`
`
`
`
`
`
`
`10028290
`
`
`
`
`/s/ Susan Langworthy
`
`- 4 -
`
`
`
`